PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 86 filers reported holding PASSAGE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | 0.0% | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2023 | $31,742 | +23.0% | 33,168 | +77.3% | 0.00% | – |
| Q4 2022 | $25,814 | -26.2% | 18,706 | -33.7% | 0.00% | – |
| Q3 2022 | $35,000 | -62.0% | 28,218 | -27.7% | 0.00% | – |
| Q2 2022 | $92,000 | -43.6% | 39,023 | -25.5% | 0.00% | – |
| Q1 2022 | $163,000 | -71.8% | 52,348 | -42.6% | 0.00% | – |
| Q4 2021 | $579,000 | +70.3% | 91,188 | +167.5% | 0.00% | – |
| Q3 2021 | $340,000 | -29.6% | 34,093 | -6.7% | 0.00% | – |
| Q2 2021 | $483,000 | -5.7% | 36,529 | +24.8% | 0.00% | – |
| Q1 2021 | $512,000 | +84.8% | 29,280 | +170.4% | 0.00% | – |
| Q4 2020 | $277,000 | +489.4% | 10,829 | +203.6% | 0.00% | – |
| Q3 2020 | $47,000 | -71.2% | 3,567 | -40.2% | 0.00% | – |
| Q2 2020 | $163,000 | +30.4% | 5,963 | -24.9% | 0.00% | – |
| Q1 2020 | $125,000 | – | 7,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $6,844,481 | 14.16% |
| Lynx1 Capital Management LP | 3,355,917 | $4,631,165 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,447,132 | 2.50% |
| BML Capital Management, LLC | 337,467 | $465,704 | 0.44% |
| Frazier Life Sciences Management, L.P. | 3,756,915 | $5,184,543 | 0.32% |
| Orbimed Advisors | 8,931,999 | $12,326,159 | 0.24% |
| Newtyn Management, LLC | 790,000 | $1,090,200 | 0.22% |
| Oasis Management Co Ltd. | 240,000 | $331,200 | 0.07% |
| Rubric Capital Management LP | 822,105 | $1,134,505 | 0.05% |
| Marquette Asset Management, LLC | 67,101 | $92,599 | 0.03% |